CSIMarket Company Name, Ticker, Industry, else..


Talis Biomedical Corporation  (TLIS)
Other Ticker:  
 

Talis Biomedical Corporation

TLIS's Fundamental analysis



Talis Biomedical's sales fell by -61.78 % in I. Quarter 2023 from the same quarter a year ago. Ranking at No. 2513

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -13.45 %

Talis Biomedical net loss deacreased by in I. Quarter 2023 year on year, Talis Biomedical net loss increased by -46.05 % in I. Quarter 2023 year on year,

• More on TLIS's Growth


Talis Biomedical
realized net loss in trailing twelve months.

Talis Biomedical realized cash outflow of $ -2.75per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.63.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.95.


• More on TLIS's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 7.56
 Tangible Book Value (Per Share $) 4.11

Talis Biomedical
realized net loss in trailing twelve months.

Talis Biomedical realized cash outflow of $ -2.75per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 4.63.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.95.

Talis Biomedical Price to Book Ratio is at 0.12 lower than Indusry Avg. of 4.18. and lower than S&P 500 Avg. of 1405.53

• More on TLIS's Valuation

•  Market Capitalization (Millions $) 13
•  Shares Outstanding (Millions) 27
•  Employees -
•  Revenues (TTM) (Millions $) 3
•  Net Income (TTM) (Millions $) -98
•  Cash Flow (TTM) (Millions $) -74
•  Capital Exp. (TTM) (Millions $) -1
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 7.56
•  Tangible Book Value (Per Share $) 4.11

•  Market Capitalization (Millions $) 13
•  Shares Outstanding (Millions) 27
•  Employees -
•  Revenues (TTM) (Millions $) 3
•  Net Income (TTM) (Millions $) -98
•  Cash Flow (TTM) (Millions $) -74
•  Capital Exp. (TTM) (Millions $) -1





  Ratio
•   Capital Ratio (MRQ) 10.34
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.21
•  Asset Turnover Ratio (TTM) 0.02
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071